Skip to content

Clinical trials

Recruiting Hemorrhage trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Status: Recruiting Country / region: United States Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20151
20161
20171
20191
20201
20211
20224
20231
20246
202518
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Regeneron Pharmaceuticals3
Pfizer2
Takeda2
University of Florida2
Washington University School of Medicine2
Boston Children's Hospital1
Burke Rehabilitation Hospital1
Cayuga Biotech, Inc.1
Columbia University1
CorVita Science Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage42
Thrombosis6
Atrial Fibrillation5
Stroke5
Hemophilia A4
Brain Diseases3
Central Nervous System Diseases3
Cerebrovascular Disorders3
Hemostatic Disorders3
Vascular Diseases3

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.